Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1476 results found. Search for [ trials for COVID-19 ]

Results 1 to 21 of 1476
BusinessToday.In
May 16, 2021
Russian Ambassador to India Nikolay Kudashev termed the delivery of the second consignment of Sputnik V vaccine in the country \"very timely\"


BusinessToday.In
May 15, 2021
\"We have asked them (Dr Reddy's) how many doses and by what time they can provide. No response has come from their side as yet,\" Kejriwal said.


Shailendra Shukla
New Delhi, May 15, 2021
Extension of gap between Covishield doses 'reasonable approach', says Dr FauciAmid the furore over the extension of the gap between two doses of Covishield, White House chief medical adviser Dr Anthony Fauci said that it is a 'reasonable approach'. He said that if one is in a situation that India finds itself in currently, then one would have to try and figure out other ways to get as many as possible vaccinated. The comments come after the government announced on Thursday that the gap betwe...


PTI
May 14, 2021
The court also asked the Centre what quantities of the antibody cocktail would be required for the purpose of reducing demand for Tocilizumab


Reuters
May 14, 2021
The Russian Direct Investment Fund (RDIF), which is responsible for marketing the vaccine abroad, said the manufacturing capacity for Sputnik V was increasing globally as new manufacturers come on board.


Reuters
May 14, 2021
Our study demonstrates that peak antibody responses after the second Pfizer vaccine are markedly enhanced in older people when this is delayed to 12 weeks, Helen Parry, an author of the study based at the University of Birmingham, said


BusinessToday.In
May 13, 2021
Bharat Biotech has been producing Covaxin at its Biosafety Level-3 (BSL-3) facilities in Hyderabad and Bengaluru, where production capacity had been enhanced in a step-wise manner


BusinessToday.In
May 13, 2021
Vaccine scarcity in many low and middle-income nations has prompted researchers and public health officials to examine strategies such as mixing two different shots


BusinessToday.In
May 13, 2021
Union Health Ministry had in April issued clinical guidelines for the management of coronavirus patients, underlining which medication should be given to COVID-19 patients and at what stage


BusinessToday.In
May 13, 2021
Hyderabad-based Bharat Biotech had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers


BusinessToday.In
New Delhi, May 12, 2021
Prime Minister Narendra Modi will not travel to the UK to attend the G-7 summit in June due to the coronavirus situation in the country; To strengthen corporate governance practices and disclosure requirements, Sebi has notified new rules, including that top 1,000 listed firms will have to formulate a dividend distribution policy; Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. Watch this and more news on News Blast. BT podcast : 'Outright lies', says China on reports of weaponising COVID-19 in 2015


India Today Tech
New Delhi, May 12, 2021
Milagrow's robots were of significance during Covid times as some hospitals started using Milagrow's robots to shield doctors and healthcare care workers fromthe virus.


BusinessToday.In
May 12, 2021
Dr Reddy's has also tied up with Russian Direct Investment Fund, Russia's sovereign wealth fund that has bankrolled Sputnik V. It has also collaborated with DRDO to develop an anti-Covid drug, 2-deoxy-D-glucose (2-DG), which has also received approval from DCGI


Rashi Bisaria
New Delhi, May 12, 2021
'Outright lies': China on reports that its military scientists probed weaponising COVID-19 in 2015China on Monday termed as \"outright lies\", the media reports that its military scientists investigated weaponising coronaviruses five years before the COVID-19 pandemic outbreak and said it is an attempt by the US to smear the country. The US State Department reportedly obtained the \"bombshell\" documents, which were written by Chinese military scientists and senior public health officials in ...


PTI
May 12, 2021
Bharat Biotech has commenced direct supply of Covaxin with effect from May 1 to several states based on the allocations received by the central government, the company's Joint Managing Director Suchitra Ella had earlier said


PTI
May 12, 2021
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur


BusinessToday.In
May 11, 2021
CSIR's research paper is based on a nationwide serosurvey conducted by the institute, which also concludes that people who eat meat are more prone to contracting coronavirus than those who are vegetarians. The study attributed high fibre content in vegetarian diets to stronger immunity among vegetarians


BusinessToday.In
May 11, 2021
Scientists from the UK, Italy, Spain and Japan claim a significant reduction in mortality, time to recovery and viral clearance in COVID-19 patients treated with Ivermectin but WHO has recommended against its general use


BusinessToday.In
May 11, 2021
Claims linking 5G technology with COVID-19 pandemic are false and have no scientific basis, says the Centre. Testing of 5G network has not even started anywhere in India


BusinessToday.In
May 10, 2021
The anti-Covid oral drug has been developed by the Defence Research and Development Organisation's (DRDO's) leading laboratory- Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy's Laboratories


PAGES 1 OF 74  12345